Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer

Clinical trial NCT01045304 · COMPLETED

Trial details

NCT number: NCT01045304
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer, Metastatic

Start date: 2010-02-01
Primary completion: 2011-03-01
Enrollment: 163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.